Met Life Investment Management, LLC Theravance Biopharma, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 26,668 shares of TBPH stock, worth $248,545. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,668
Previous 26,668
-0.0%
Holding current value
$248,545
Previous $214,000
16.82%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding TBPH
# of Institutions
129Shares Held
46.5MCall Options Held
600Put Options Held
300-
Madison Avenue Partners, LP New York, NY9.51MShares$88.6 Million14.29% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$69.5 Million2.02% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$44.3 Million9.1% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$35.2 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$25.7 Million2.79% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $622M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...